Multiomics Analysis Reveals the Potential Sleep-Enhancing Peptide from Milk Casein Hydrolysate and Its Synergic Mechanism via Regulating the Key Hub CaMKII Pathway in Chronic Stressed Mice.
Sleep research just got more interesting: a team in China pinpointed a milk-derived peptide that cranked up sleep duration in chronically stressed mice. The peptide, YQEPVLGPVR (or YQ10 for short), comes from casein hydrolysate—a familiar protein fragment for anyone following bioactive peptide research. But here’s the kicker: YQ10 doesn’t just help mice sleep longer. It goes after the CaMKII pathway, a core regulatory hub tied to neuroinflammation and neurotransmitter systems.
J Agric Food Chem
by Qian J, Huang Z, Zheng L et al.
“Multiomics Analysis Reveals the Potential Sleep-Enhancing Peptide from Milk Casein Hydrolysate and Its Synergic Mechanism via Regulating the Key Hub CaMKII Pathway in Chronic Stressed Mice. Qian J(1)(2), Huang Z(1), Zheng L(1)(2), Zhao M(1)(2). Author information: (1)School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China. (2)Guangdong Food Green Processing and Nutrition Regulation Technologies Research Center, Guangzhou 510650, China. Casein hydrolysate (CMH) was proved to exert strong sleep-enhancing effects by vital amino acid metabolisms, GABAergic system, and cAMP signaling pathway in our previous study. Whether there existed a novel active peptide in CMH and its underlying synergic mechanism remain unknown. This study aims to explore novel potent sleep-enhancing peptides in CMH and to systematically investigate its underlying mechanisms by multiomics analysis. Our results showed that many potent sleep-enhancing Tyr-based peptides were released by CMH. Considering potential structural features and contents, YQEPVLGPVR (YQ10) was screened, which significantly prolonged sleep duration and recovered the corticosterone level. Moreover, ten crucial DEGs and DEMs were revealed by omics analysis. YQ10 might regulate CaMKII and neuroinflammatory pathways to communicate with GABAergic and cAMP signaling pathways, particularly regulating CaMKII, IL-1β, and IL-6, which was validated by vital factors/protein expressions and antagonist experiments. These findings could provide a theoretic basis to explore potential sleep-enhancing mechanisms of Tyr-based peptides.”
The researchers didn’t just look at outcomes. They ran a full multiomics analysis—think genomics, metabolomics, and then some—to figure out what’s actually happening at the molecular level. YQ10 hit several targets:
Prolonged sleep duration in stressed mice
Brought stress hormones (corticosterone) back to baseline
Regulated key inflammatory markers: IL-1β and IL-6
Interacted with GABAergic and cAMP pathways, both central to sleep regulation
Key takeaway: We’re not talking about a random milk peptide. This is a Tyr-based sequence that was specifically screened for its structure and function, then validated across gene and protein expression. The team even ran antagonist experiments to prove the pathway involvement.
For anyone mapping out new sleep-enhancing research compounds, this study is a reminder that food-derived peptides still have surprises left. The CaMKII pathway now looks like a prime target for peptide modulation, especially if you’re evaluating neuroinflammation or stress models.
Curious about other functional sequences and related findings? Dive into the peptide research index for more leads. Milk protein hydrolysates aren’t just for nutrition—they’re a hotbed of untapped research compounds.
Related Reading
The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.
News · J Med ChemStructure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.
News · J Nucl MedCombining an α(v)β(6)-Targeted (177)Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.